Search company, investor...

Applikon Biotechnology

Founded Year



Acquired | Acquired



About Applikon Biotechnology

Applikon Biotechnology is a privately owned Dutch company developing, manufacturing and supplying bioreactor systems for both research and production use.

Headquarters Location

Heertjeslaan 2

Delft, 2629 JG,


+31(0)10-208 35 55

Missing: Applikon Biotechnology's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Applikon Biotechnology's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Applikon Biotechnology Patents

Applikon Biotechnology has filed 1 patent.

The 3 most popular patent topics include:

  • Biochemical engineering
  • Biological engineering
  • Bioreactors
patents chart

Application Date

Grant Date


Related Topics



Biotechnology, Bioreactors, Biological engineering, Biochemical engineering, Tissue engineering


Application Date


Grant Date


Related Topics

Biotechnology, Bioreactors, Biological engineering, Biochemical engineering, Tissue engineering



Latest Applikon Biotechnology News

$31.5 Billion Worldwide Single-Use Bioprocessing Industry to 2027 - Featuring Applikon Biotechnology, Boehringer Ingelheim and Cesco Bioengineering Among Others

Jul 15, 2022

The global single-use bioprocessing market reached a value of US$ 12.2 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 31.5 Billion by 2027, exhibiting a CAGR of 17.13% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor. Single-use bioprocessing, or disposables, consists of various pharmaceutical solutions and products that are designed to be used once and then discarded. Media bags, containers, filtration assemblies, single-use bioreactors, disposable mixers, tubes, connectors and samplers are some of the most commonly used single-use bioprocessing products. These products are often used in the production of monoclonal antibodies, vaccines, plant cell cultivation and specific cell therapies. They are also utilized by biopharmaceutical manufacturers and life science research organizations for increasing productivity and ease of disposal with minimal risk of cross-contamination. The increasing demand for pharmaceutical products across the globe is one of the key factors driving the growth of the market. The single-use bioprocessing technology is commonly used in media preparation and shipping of biologics while manufacturing pharmaceuticals. Furthermore, there is a growing preference for single-use products manufactured using high-grade polymer materials and plastic composites as they offer enhanced integral strength and aid in reducing the overall operational costs. It also ensures continuity in biomanufacturing, which is further providing a boost to the market growth. Additionally, various technological advancements, including the utilization of automation, big data and machine learning (ML) solutions in bioprocessing, are creating a positive outlook for the market growth. Such technological solutions aid in developing analytical models for predicting errors and improving accuracy during medical procedures. Other factors, including significant developments in the healthcare sector and extensive research and development (R&D) activities, are projected to drive the market further. Competitive Landscape: The report has also analysed the competitive landscape of the market with some of the key players being Applikon Biotechnology, Boehringer Ingelheim, Cesco Bioengineering Company, Corning Inc., Danaher Corporation, Entegris, Eppendorf AG, Finesse Solutions Inc., GE Healthcare, Infors, Merck Millipore, Rentschler Biotechnologie, Sartorius Stedim Biotech, Thermo Fisher Scientific, 3M Company, etc. Key Questions Answered in This Report: How has the global single-use bioprocessing market performed so far and how will it perform in the coming years? What are the key regional markets? What has been the impact of COVID-19 on the global single-use bioprocessing market? What is the breakup of the market based on the product type? What is the breakup of the market based on the application? What is the breakup of the market based on the end-use? What is the breakup of the market based on the end-user? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the market? What is the structure of the global single-use bioprocessing market and who are the key players? What is the degree of competition in the market? Key Topics Covered:

Applikon Biotechnology Frequently Asked Questions (FAQ)

  • When was Applikon Biotechnology founded?

    Applikon Biotechnology was founded in 2008.

  • Where is Applikon Biotechnology's headquarters?

    Applikon Biotechnology's headquarters is located at Heertjeslaan 2, Delft.

  • What is Applikon Biotechnology's latest funding round?

    Applikon Biotechnology's latest funding round is Acquired.

  • Who are the investors of Applikon Biotechnology?

    Investors of Applikon Biotechnology include Getinge.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.